Physician

Refat Baridi, MD

According to 2025 Medicare claims, Refat Baridi, MD (NPI: 1285622621) practices medical oncology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is PREMIER SUBURBAN MEDICAL GROUP, PLLC (NPI: 1902412950; TIN: 853000302) and primary practice location at 60517-2356.

Baridi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 735 traditional Medicare patients, billed 379,378 HCPCS/CPT codes, and received $5,220,399 in Medicare payments. The top billing code was J0897 (Injection, denosumab, 1 mg). Part D data shows 31 prescription claims totaling $288,985 in drug costs, led by Revlimid (Lenalidomide). DME data shows 34 claims. Open Payments data shows 65 records totaling $1,519. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $6,698,973 to $5,220,399. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $458,445 and ending at $288,985. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $10,380 to $7,460.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	842	591,315	$6,698,973
2016	934	614,097	$8,075,849
2017	617	401,498	$5,913,546
2018	564	404,598	$5,688,289
2019	621	416,853	$5,918,379
2020	471	339,487	$4,848,896
2021	330	80,586	$943,793
2022	528	260,442	$2,818,885
2023	633	292,688	$3,717,948
2024	735	379,378	$5,220,399

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	85	274	$458,445
2016	96	229	$240,791
2017	80	259	$800,964
2018	94	231	$1,045,231
2019	105	315	$1,150,291
2020	63	199	$1,266,584
2021	N/R	22	$201,074
2022	19	44	$368,586
2023	N/R	35	$472,571
2024	N/R	31	$288,985

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	26	166	$47,399
2016	N/R	198	$69,641
2017	N/R	34	$9,738
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	97	$9,201
2023	N/R	33	$6,153
2024	N/R	34	$7,107

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J0897	Injection, denosumab, 1 mg	185	26,160	$20
96372	Injection of drug or substance under skin or into muscle	304	1,132	$11
80053	Blood test, comprehensive group of blood chemicals	509	2,927	$10
36415	Insertion of needle into vein for collection of blood sample	518	1,949	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	522	3,100	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	14	392	$172,038

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0781	Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient	Y	N/R	34	$7,107

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	65	$1,519	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Refat Baridi, MD?

Tedicare shows public-source Medicare data for Refat Baridi, MD (NPI 1285622621), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Refat Baridi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Refat Baridi, MD?

Refat Baridi, MD is linked to PREMIER SUBURBAN MEDICAL GROUP, PLLC (billing NPI 1902412950) in the available physician profile data.

Does Refat Baridi, MD have Open Payments data?

Refat Baridi, MD has 65 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.